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Glial cells release molecules that influence
brain development, function, and disease. Calcium-
dependent exocytosis has been proposed as
potential release mechanism in astroglia, but the
physiological relevance of ‘‘gliotransmission’’ in vivo
remains controversial. We focused on the impact of
glial exocytosis on sensory transduction in the
retina. To this end, we generated transgenic mice
to block exocytosis by Cre recombinase-dependent
expression of the clostridial botulinum neurotoxin
serotype B light chain, which cleaves vesicle-
associated membrane protein 1-3. Ubiquitous and
neuronal toxin expression caused perinatal lethality
and a reduction of synaptic transmission thus vali-
dating transgene function. Toxin expression inMu¨ller
cells inhibited vesicular glutamate release and
impaired glial volume regulation but left retinal
histology and visual processing unaffected. Our
model to study gliotransmission in vivo reveals
specific functions of exocytotic glutamate release
in retinal glia.504 Neuron 74, 504–516, May 10, 2012 ª2012 Elsevier Inc.INTRODUCTION
Neuron-glia interactions are mediated in part by the release of
substances from glial cells (Barres, 2008; Wang and Bordey,
2008; Halassa and Haydon, 2010; Perea and Araque, 2010).
Studies on in situ preparations and in vivo models suggest that
astroglial release of molecules like amino acids, peptides, and
nucleotides modulates electrical activity in neurons (Parri et al.,
2001; Angulo et al., 2004; Fellin et al., 2004; Liu et al., 2004),
synaptic transmission (Fiacco and McCarthy, 2004; Panatier
et al., 2006; Jourdain et al., 2007; Perea and Araque, 2007;
Panatier et al., 2011), and blood flow (Gordon et al., 2008;
Petzold et al., 2008). Recent studies show that glial release influ-
ences memory formation (Suzuki et al., 2011), motor coordina-
tion (Kakegawa et al., 2011), and respiration (Gourine et al.,
2010; Huxtable et al., 2010). Calcium-dependent exocytosis
has been proposed as a mechanism for glial substance, also
named ‘‘gliotransmission,’’ release based on evidence that as-
troglial cells express vesicular transmitter transporters (Bezzi
et al., 2004; Ormel et al., 2012) and components of the exocytotic
machinery (Wilhelm et al., 2004; Zhang et al., 2004; Schubert
et al., 2011) and that they show calcium-dependent release
in vitro (Parpura et al., 1994; Araque et al., 2000; Mothet et al.,
2005; Li et al., 2008; Marchaland et al., 2008) and in situ (Pasti
Figure 1. Generation and Validation of iBot Mice
(A) Transgene for Cre-dependent expression of BoNT/B and EGFP.
(B) Perinatal lethality among bigenic, monogenic, and wild-type offspring from
matings between the iBot line and the Tg(CMV-Cre) line with ubiquitous
expression of constitutively active Cre (n = 110 pups from 19 litters). Inset,
fraction of pups with indicated genotypes. Note the drastically enhanced
perinatal lethality and reduced number of pups in bigenic (n = 12 pups)
compared to monogenic (Cre: n = 29; Tox: n = 36) or wild-type mice (n = 33;
Pearson’s Chi square test).
(C) Mean amplitudes of synaptic responses of Purkinje cells to parallel fiber
stimulation at indicated intensities. Whole-cell patch-clamp recordings from
Purkinje cells of Tam-injected bigenic mice with neuronal expression of
BoNT/B (red filled circles; n = 11 PCs; n = 3 animals, iBot 3 Tg(Prnp-CreERT))
or of monogenic littermates (black empty circles; n = 8 PCs; n = 4 animals,
iBot). Whiskers, standard deviation. Note the reduced size of evoked synaptic
currents in Tam-injected bigenic mice compared tomonogenic littermates (p =
0; repeated-measures ANOVA, Tukey post hoc test). Inset, whole-cell currents
(average of 5 traces) evoked by parallel fiber stimulation (30, 60, and 90 V;
70 ms) in Purkinje cells from amonogenic (black, left) and a bigenic mouse (red,
right).
(D) False-color fluorescence micrographs of cerebellar sections from an
adult Tam-injected wild-type (left) and bigenic mouse [middle; iBot 3
Tg(Prnp-CreERT)] that were subjected to immunohistochemical staining for
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2010; Perea and Araque, 2010). However, the physiologic re-
levance of exocytosis in astroglial cells is controversial (Fiacco
et al., 2009; Hamilton and Attwell, 2010; Nedergaard and
Verkhratsky, 2012), because there are very few experimental
models to address this topic in vivo.
We developed a new transgenic approach to block calcium-
dependent exocytosis in vivo by temporally controlled, cell-
specific expression of clostridial botulinum neurotoxin sero-
type B light chain (BoNT/B) using the Cre/loxP system. BoNT/B
blocks exocytosis efficiently by cleaving vesicle-associated
membrane protein 2/synaptobrevin 2 (VAMP2), a component
of the soluble N-ethylmaleimide-sensitive factor-attachment
protein receptor (SNARE) complex (Schiavo et al., 1992). In addi-
tion, BoNT/B cleaves VAMP1 and VAMP3 (Humeau et al., 2000).
We validated the function of the transgene by ubiquitous and
neuron-specific expression using suitable Cre recombinase
(Cre)-expressing lines.
To reveal potential physiological roles of glial exocytosis in vivo
we focused on the retina as a highly accessible sensory system.
The predominant glial element of the retina are Mu¨ller cells,
which represent a subtype of astroglia. They span across retinal
layers and contact all neurons (Reichenbach and Bringmann,
2010). Mu¨ller cells ensheath synapses in plexiform layers (Burris
et al., 2002), they express VAMP2 and VAMP3 (Roesch et al.,
2008), and they influence the activity of retinal neurons by the
release of substances (Newman and Zahs, 1998; Newman,
2003; Stevens et al., 2003; Bringmann et al., 2006). To block glial
exocytosis, we targeted the toxin to Mu¨ller cells using a trans-
genic line, where the expression of tamoxifen-inducible Cre
recombinase (CreERT2) is controlled by promoter elements
of the glutamate/aspartate transporter (Glast/Slc1a3; Slezak
et al., 2007). Our results show that toxin-mediated elimination
of VAMPs in Mu¨ller cells inhibits vesicular glutamate release
and impairs volume regulation in these cells, but does not affect
retinal histology and visual processing.
RESULTS
Generation and Validation of iBot Mice
To generate the transgene, we inserted cDNA encoding for
BoNT/B in a cassette that enables Cre-dependent induction of
gene expression and EGFP-mediated labeling of cells (Endoh
et al., 2002; Figure 1A). Out of 13 founder lines, two showed
germline transmission. One of these lines, B6;FVB-Tg(CAG-
boNT/B,EGFP)U75-56Fwp/J (JAX Stock No. 018056), subse-
quently referred to as the iBot line, was retained for further
analysis and validated in two ways. First, iBot mice were crossed
to a transgenic line, where Cre is expressed in all cells (Tg(CMV-
Cre); Dupe´ et al., 1997). Ubiquitous induction of the toxin should
phenocopy the perinatal lethality of VAMP2 knockout mice
(Schoch et al., 2001). Indeed, bigenic mice were born atEGFP. Overlay on the right, double-staining with antibody against EGFP
(green) and Kv3.1b (red), which labels granule cells. Scale bar: 10 mm. Mice
shown in (C) and (D) received Tam between P5 and P9 by intraperitoneal
injection of lactating mothers and were analyzed three weeks after the last
injection.
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Figure 2. Transgenic Expression of BoNT/B
Inhibits Vesicular Glutamate Release from Mu¨ller
Cells
(A) False-color fluorescence micrographs of retinal
sections from an adult, Tam-injectedmonogenic (left; iBot)
and a bigenic mouse (right; iBot3 Tg(Glast-CreERT2)) that
were subjected to immunohistochemical staining with
antibodies against EGFP (green) and against CRALBP
(red). The ganglion cell layer is at the bottom. Scale bar:
20 mm.
(B) Mean levels of VAMP2 normalized to SYP content
measured by surface plasmon resonance in retinal
lysates from adult bigenic mice (iBot3 Tg(Glast-CreERT2))
treated with Tam (Tox; n = 5) or from control mice (Con; n =
5; vehicle-treated bigenic or Tam-injected monogenic
mice). Whiskers, standard deviation. The normalized
VAMP2 content was significantly reduced in Tam-injected
bigenic mice compared to control littermates (Mann-
Whitney test).
(C) Micrographs showing intracellular EGFP (top) and
extracellular resorufin (bottom) fluorescence in Mu¨ller cell
acutely isolated from a Tam-injected bigenic mouse. Re-
sorufin was generated outside the cell as enzymes and
substrates were added to the extracellular solution. Scale
bar: 5 mm.
(D) Higher-magnification micrographs showing resorufin
fluorescence before and after UV stimulation above the endfoot of a Mu¨ller cell from a Tam-injected monogenic mouse. Scale bar: 5 mm.
(E) Left, representative time courses of the resorufin signal measured above endfeet of acutely isolatedMu¨ller cells. Note the UV-induced increase in fluorescence
in cells from Tam-injected monogenic mouse (thick line), which is reduced by bafilomycin (200 nM, thin line) or by BoNT/B expression in Mu¨ller cells from
a Tam-injected bigenic mouse (red line). ADU, analog-to-digital units. Right, mean peak amplitudes of the UV-induced resorufin transients from Tam-injected
mono- and bigenic mice under the indicated conditions. ‘‘Enzymes’’ signifies absence or presence of glutamate converting enzymes in extracellular solution.
Whiskers indicate standard error and each column represents cells from three to six animals (column 1, n = 13 cells; 2, n = 14; 3, n = 68 (29 + 39); 4, n = 21; 5, n = 32;
Mann-Whitney test).
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littermates and notably, all bigenic offspring died within 1 day
after birth, whereas perinatal death rates among control mice
were significantly lower (Figure 1B). Second, we tested whether
neuronal expression of BoNT/B inhibits SNARE-dependent
synaptic transmission (Poulain et al., 1988). To this end, iBot
mice were crossed with a line, in which the prion promoter
targets an inducible version of Cre (CreERT) to cerebellar
neurons (line 28.6, Tg(Prnp-CreERT); Weber et al., 2001).
Whole-cell patch-clamp recordings from Purkinje cells revealed
a strong reduction of synaptic responses to parallel fiber stimu-
lation in Tamoxifen (Tam)-injected bigenic mice compared to
Tam-injected monogenic littermates (Figure 1C). Immunohisto-
chemical staining revealed the presence of EGFP, which is coex-
pressed with the toxin, in the cerebellar granular and molecular
layer of bigenic mice (Figure 1D).
Together, these results proved that the iBot line allows for
cell-specific block of SNARE-dependent exocytosis.
Inhibition of Vesicular Glutamate Release from Retinal
Mu¨ller Cells by BoNT/B Expression
Next, we induced BoNT/B expression in retinal glia by crossing
iBot mice with the Tg(Glast-CreERT2)T45-72 line, which ex-
presses Tam-dependent Cre recombinase in Mu¨ller cells (Slezak
et al., 2007). Since the toxin cannot be visualized, we used immu-
nohistochemical staining for EGFP to detect the transgene in
Mu¨ller cells. As shown in Figure 2A, adult Tam-injected bigenic
mice showed EGFP expression in cellular retinaldehyde binding506 Neuron 74, 504–516, May 10, 2012 ª2012 Elsevier Inc.protein (CRALBP)-positive Mu¨ller cells, whereas monogenic
littermates showed no EGFP staining. The targeting efficacy
was on average 55% ± 8% EGFP-positive cells among all
CRALBP-positive Mu¨ller cells (n = 4 bigenic mice). The limited
sensitivity of immunohistochemical detection may underesti-
mate the targeting efficacy. To test whether the toxin is active,
we determined retinal VAMP2 levels by surface plasmon reso-
nance (Ferracci et al., 2005). In retinal lysates from Tam-injected
bigenic mice, levels of VAMP2 normalized to synaptophysin
(SYP) content were significantly decreased compared to
vehicle-injected bigenic mice or Tam-injected monogenic or
wild-type littermates (Figure 2B) indicating proteolyic activity of
the toxin in retinae from Tam-injected bigenic mice.
To address whether BoNT/B expression blocks calcium-
dependent exocytosis from Mu¨ller cells, we established an
assay to measure calcium-induced glutamate release from
acutely isolated cells. We evoked intracellular calcium transients
by UV-induced uncaging of calcium from the photolabile
chelator o-nitrophenyl EGTA (NP-EGTA) and we visualized
cellular glutamate release by a modified version of a sensitive
fluorometric enzyme assay (Akagi et al., 2003; Figures 2C–2E).
End product of the glutamate-specific reaction is the fluorophore
resorufin, which was produced and detected outside the cells
(Figures 2C and 2D). UV stimulation of Mu¨ller cells from Tam-
injected monogenic mice resulted in a robust and transient
increase of resorufin fluorescence above their endfeet (Figures
2D and 2E). Several control experiments confirmed that this
signal reflected local calcium-evoked glutamate release from
Figure 3. Retinal Morphology with or without Glial Toxin Expression
Imaging of retinae from adult, Tam-injected mono- and bigenic mice (iBot3 Tg(Glast-CreERT2)) using OCT (A), SLO (B), immunohistochemistry (C), and electron
microscopy (D). SLO imaging was performed with green laser illumination (RF; 514 nm) and fundus autofluorescence imaging (AF; 488 nm) at 20 and 10 for
fundus overview and magnification.
(C) Representative fluorescence micrographs of retinal sections stained with the nuclear marker TO-PRO-3 and with antibodies against VGLUT1 and PKCa to
reveal synapses and bipolar cells, respectively, and with the cone marker peanut agglutinin (PNA). The ganglion cell layer is at the bottom. Scale bar: 20 mm.
(D) Representative electron microscopic images. From top to bottom: outer nuclear layer, outer plexiform layer, inner nuclear layer and inner plexiform/ganglion
cell layer. Scale bar: 4 mm.
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it was measured at 30 mm distance from the endfeet (data not
shown), when NP-EGTA was omitted and when glutamate-con-
verting enzymes were removed from the extracellular solution
(Figure 2E). This assay allowed us to test whether toxin expres-
sion reduces glutamate release fromMu¨ller cells. Our recordings
revealed that indeed, the amplitude of the UV-induced resorufin
signal was significantly reduced in EGFP-positive Mu¨ller cells of
Tam-injected bigenic mice compared to cells from Tam-injected
monogenic mice (Figure 2E). Notably, bafilomycin A1, which
blocks vesicular uptake of glutamate (Moriyama et al., 1990),
reduced the calcium-induced fluorescence transients in cells
from Tam-injected monogenic mice to the same extent as
BoNT/B (Figure 2E).
These experiments provided direct evidence for vesicular
glutamate release from Mu¨ller cells and confirmed its reduction
by transgenic expression of BoNT/B, which validates our model
at the cellular level. The fact that bafilomycin or the toxin did not
completely abolish the signal suggests the presence of non-
vesicular glutamate release.Retinal Morphology after BoNT/B Expression
in Mu¨ller Cells
Next, we asked whether glial expression of the toxin affects the
retinal morphology. We first examined retinae in living iBot mice
crossed with Tg(Glast-CreERT2) mice using spectral domain
optical coherence tomography (OCT) and scanning laser
ophthalmoscopy (SLO) (Figure 3). OCT imaging revealed normal
retinal layering in Tam-injected bigenic mice as in their mono-
genic littermates (Figure 3A). Similarly, SLO imaging did not
reveal differences between bi- and monogenic mice, except
for the presence of autofluorescence (Figure 3B), which was
caused by EGFP expression in Mu¨ller cells. To further examine
the retinal morphology, we performed immunohistochemical
staining of retinal sections from Tam-injected mice with cell-
and layer-specific markers (Figure 3C). These experiments re-
vealed no detectable differences in the histology of retinae from
Tam-injected monogenic and bigenic mice (Figures 2A and 3C).
Finally, we addressed whether toxin expression in Mu¨ller cells
affects the ultrastructure of the retina by electron microscopy.
However, a comparison of Tam-injected mono- and bigenicNeuron 74, 504–516, May 10, 2012 ª2012 Elsevier Inc. 507
Figure 4. Volume Regulation in Mu¨ller Cells with or without Toxin
Expression
(A) Proposed signaling pathway that mediates volume regulation inMu¨ller cells
and implies vesicular glutamate release (Wurm et al., 2008).
(B) False-color fluorescence micrographs showing an EGFP-expressing
Mu¨ller cell (green) in a retinal slice from an adult, Tam-injected bigenic mouse
(iBot 3 Tg(Glast-CreERT2)) following staining with the vital dye Mitotracker
Orange (10 mM), which labels Mu¨ller cells (red). Scale bar: 10 mm.
(C) Mean cross-sectional areas of Mu¨ller cells (MC) and of neuronal cells (NC)
in the ganglion cell layer from Tam-injected mono- (white) and bigenic (black)
mice (n = 30 to 86 per experimental group from 2–3 mice per genotype).
(D) Mean cross-sectional areas of Mu¨ller cell somata from Tam-injectedmono-
and bigenic mice (n = 7–16 per experimental group from 2–3 animals per
genotype) after superfusion for 4 min with hypotonic solution normalized to
area values measured before hypotonic challenge. Changes were recorded
in the absence () or presence of glutamate (GL; 1 mM) or of VEGF
(VE; 30 ng/ml). Note that only glutamate, but not VEGF restored volume
regulation in Mu¨ller cells from bigenic mice as predicted. Swelling could be
induced in Mu¨ller cells from monogenic animals by barium chloride and this
effect was blocked by co-application of glutamate or VEGF.
(E) Fluorescence micrographs of a retinal whole-mount from a monogenic
mouse that was stained with FM1-43 (2 mM) to visualize plasma membranes.
The focus was set on the ganglion cell layer, where neuronal cell bodies
(asterisks) can be discriminated from other structures such as blood vessels
and nerve fibers (arrowheads). Scale bar: 10 mm.
(F) Mean cross-sectional area of neuronal somata in the ganglion cell layer
from adult, Tam-injected mono- and bigenic mice (n = 43–65 per experimental
Neuron
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508 Neuron 74, 504–516, May 10, 2012 ª2012 Elsevier Inc.mice did not reveal perceptible differences between the two
genotypes (Figure 3D).
Volume Regulation after BoNT/B Expression in Mu¨ller
Cells
Previous studies suggested that a glutamatergic-purinergic
signaling pathway prevents hypoosmotic swelling of Mu¨ller cells
in the rodent retina by vesicular release of glutamate (Wurm
et al., 2008, 2010; Figure 4A). Therefore, we tested whether
this pathway was defect in BoNT/B-expressing Mu¨ller cells.
Mu¨ller cells from Tam-injected bigenic mice, which expressed
the BoNT/B transgene as indicated by the presence of EGFP
(Figure 4B), had similar cross sectional areas as cells from
Tam-injected monogenic mice (Figure 4C). However, these cells
swelled in hypotonic solution, while Mu¨ller cells frommonogenic
animals maintained their cell volume (Figure 4D) indicating
a toxin-induced defect in volume regulation. If the swelling of
toxin-expressing Mu¨ller cells was due to the block of glutamate
release, coapplication of glutamate should prevent the swelling
of these cells. As shown in Figure 4D, this was indeed the case
thus confirming the involvement of exocytotic glutamate release
in volume regulation. Vascular endothelial growth factor (VEGF),
which activates the volume-regulating cascade upstream of
glutamate release (Wurm et al., 2008), failed to abolish swelling
of Mu¨ller cells from bigenic mice (Figure 4D), whereas it pre-
vented hypotonic swelling of Mu¨ller cells from monogenic mice
due to barium-induced block of inwardly rectifying potassium
channels (Wurm et al., 2008) (Figure 4D). Toxin expression in
Mu¨ller cells may have provoked reactive gliosis and thereby per-
turbed glial volume regulation (Pannicke et al., 2004, 2005; Sene
et al., 2009). However, levels of glial fibrillary acidic protein
(GFAP) were similar in retinae from Tam-injected mono- and
bigenic mice (data not shown). Additional hallmarks of Mu¨ller
cell reactivity are a downregulation of potassium inward currents
and an increase in membrane capacitance (Pannicke et al.,
2005). Our patch-clamp recordings revealed comparable
amplitudes of inward currents and even a significant (p < 0.02;
Student’s t test) decrease in membrane capacitance in acutely
isolated Mu¨ller cells from Tam-injected bigenic (2.4 ± 0.7 nA;
40 ± 12 pF; n = 33 cells from 8 mice) compared to monogenic
mice (2.2 ± 0.6 nA; 49 ± 12 pF; n = 29 cells, 7 mice).
The VEGF-induced glutamate release from Mu¨ller cells also
induces swelling of neurons in the ganglion cell layer indepen-
dently from a hypo-osmotic challenge (Wurm et al., 2008). To
test whether this effect was eliminated by glial toxin expression,
we measured the size of neuronal somata that were close to
endfeet of toxin- and EGFP-expressing Mu¨ller cells from Tam-
injected bigenic mice (Figure 4E). Indeed, these neurons didgroup from 2–3 animals per genotype) measured in the absence () or pres-
ence of VEGF (30 ng/ml). In the presence of VEGF neurons from monogenic
animals, but not from bigenic mice showed swelling (n = 28–65 cells from 2–3
mice). Whiskers indicate standard error and symbols indicate statistically
significant changes (Mann-Whitney tests; D: ***p < 0.001, compared to
monogenic mice under control condition; C, p < 0.05 compared to bigenic
mice under control condition;BB, p < 0.01 compared to monogenic mice in
the presence of barium; F: ***p < 0.001 compared to untreated cells from
monogenic mice; CCC, p < 0.001 compared to monogenic mice in the
presence of VEGF).
Figure 5. Responses of Retinal Ganglion Cells to Visual Stimuli Ex Vivo with or without Glial Toxin Expression
MEA recordings of spike activity in the ganglion cell layer in response to different types of visual stimuli.
(A) Fullfield black and white flashes. Left, typical responses of ON and OFF ganglion cells. Tick marks represent individual spikes; the curves represent the spike
rate averaged over several repetitions of the same stimulus. Right, maximal spike rate of retinal ganglion cells from adult, Tam-injected monogenic (n = 78 units)
and bigenic mice (n = 86; iBot 3 Tg(Glast-CreERT2)) plotted against the ON-OFF index.
(B) Sine-wave gratings of different spatial and temporal frequency and contrast. Left, response of an example cell to gratings of indicated spatial and temporal
period at 100% contrast. Right, mean normalized responses of ganglion cells to different gratings (color code as indicated on the left) plotted against the contrast
level. Whiskers, standard error. Values from Tam-injected mono- and bigenic mice were not different (p = 0.583; repeated-measures ANOVA).
(C)White-noise full-field flicker to estimate the response kinetics of ganglion cells to low- and high-contrast visual stimulation. Inset, detail of the stimulus intensity
time course illustrating a transition from low to high contrast flicker. Left, linear filter of a representative OFF ganglion cell, calculated based on spikes elicited
Neuron
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present in cells from Tam-injected monogenic animals (Fig-
ure 4E, F). As for Mu¨ller cells, the mean cross sectional area of
untreated neurons was similar in mono- and bigenic mice
(Figure 4C).
Together, these data suggest that toxin-induced block of glial
exocytosis perturbs volume regulation in Mu¨ller cells and inhibits
swelling of neuronal cells induced by glial glutamate.
Retinal Function after BoNT/B Expression in Mu¨ller
Cells
We next investigated whether toxin expression in Mu¨ller cells
affects retinal function at different levels of integration.
First, we used multielectrode arrays (MEAs) to record spike
activity in the retinal ganglion cell layer in response to visual
stimuli ex vivo (Figure 5). Previous studies showed that glial
glutamate release inhibits light-evoked ganglion cell activity
(Newman and Zahs, 1998). We stimulated retinae with different
monochromatic visual stimuli including fullfield flashes, drifting
bars, and drifting gratings to explore the spatial and temporal
response properties of ganglion cells. Ganglion cells from adult
Tam-injected mono- and bigenic mice did not differ in their
responses to simple steps in light intensity (Figure 5A) or to sinu-
soidal drifting gratings of various temporal and spatial frequency
and contrast (Figure 5B). Ganglion cells show accelerated
response kinetics in a high-contrast environment (contrast
adaptation; Baccus and Meister, 2002). We also observed this
phenomenon (Figure 5C), and there was no difference between
bi- and monogenic mice. Finally, we measured the velocity
tuning of ganglion cell spikes in response to bars drifting across
the receptive field at various velocities (Figure 5D). Again, there
was no difference between the two mouse lines. Second, we re-
corded electroretinograms (ERGs) to measure light-evoked
electrical responses of retinal layers in vivo using single flash
and flicker stimuli (Tanimoto et al., 2009; Figure 6). However,
our experiments revealed no detectable differences in the retinal
responses of Tam-injected bigenic mice compared to mono-
genic littermates (Figure 6). Third, we performed behavioral tests
to assess visual function inmice (Figure 7; Arque´ et al., 2008). For
these experiments, we used Tam-injected bi- (n = 12–13) or
monogenic (n = 12–17) males. In the novel object recognition
(NOR) test, Tam-injected bi- and monogenic mice spent more
time exploring the novel object compared to the old one, but
the mean fraction of time was similar in both groups (Figure 7A).
In the water maze test with a visible platform, bi- and monogenic
mice found the visible platform with similar latencies (Figure 7B)
and in the open field test, mice from both groups spent similar
times in the central zone (Figure 7C). Finally, we tested whether
toxin expression in glial cells affects the photic entrainment of the
circadian rhythm, which is mediated by photoreceptors andduring low (gray) and high (black) contrast episodes, respectively. The latency
differences between high and low contrast in ganglion cells from monogenic (bla
contrast are faster. There was no difference between cells from Tam-injected mo
(D) Drifting bars of different velocity. Top left, typical responses of anON ganglion c
(in mm/s). A velocity tuning curve was obtained by averaging the peak firing rate i
(50%of cells, random subset) andmean (circles; whiskers, standard error) for gang
(p = 0.98; repeated-measures ANOVA). Top right, scatter plots of parameters ob
510 Neuron 74, 504–516, May 10, 2012 ª2012 Elsevier Inc.light-sensitive cells in the ganglion cell layer (Golombek and
Rosenstein, 2010). To this end, we recorded running-wheel
activity of bi- and monogenic mice during a 12/12 hr light/dark
cycle before and after Tam-induced toxin activity. We observed
that the light-induced onset and duration of running periods and
the fraction of nocturnal activity compared to total activity were
unaffected by Tam-induced toxin expression in glial cells
(Figures 7D–7G).
Collectively, these results indicated that the response pro-
perties of ganglion cells, light-evoked potentials in retinal layers,
daylight vision, and the retinal control of circadian activity are not
noticeably affected by toxin expression in Mu¨ller cells.
DISCUSSION
To test the physiologic relevance of SNARE-dependent exocy-
tosis in glial cells in vivo, we generated and validated a transgenic
mouse line for conditional expression of BoNT/B. Our iBot mice
provide a flexible tool to study the functions of VAMP1-3 in cells
of interest (Proux-Gillardeaux et al., 2005), and they complement
the existing arsenal of models for cell-specific block of SNARE-
dependent exocytosis (Yamamoto et al., 2003; Nakashiba et al.,
2008; Zhang et al., 2008; Kerschensteiner et al., 2009; Kim et al.,
2009).
We focused on the role of glial exocytosis in the retina
and targeted BoNT/B to Mu¨ller cells by crossing iBot mice with
the Tg(Glast-CreERT2) line (Slezak et al., 2007). Using a sensitive
fluorometric assay, we provide direct evidence for calcium-
dependent vesicular release of glutamate from Mu¨ller cells.
The fact that this phenomenon occurred in acutely isolated cells
corroborates the idea that astroglial cells are capable of
exocytotic release in vivo. Our observation that neither BoNT/B
nor bafilomycin fully blocked calcium-dependent release of
glutamate fromMu¨ller cells suggests a contribution by nonvesic-
ular mechanisms (Fiacco et al., 2009; Hamilton and Attwell,
2010).
Our results indicate a specific function of vesicular glutamate
release from Mu¨ller cells. Using a battery of tests, we show
that toxin expression in Mu¨ller cells does not affect retinal struc-
ture or visual processing. This lack of effect may be due to limi-
tations of our transgenic mouse model, which does not target all
Mu¨ller cells. Unfortunately, there is currently no experimental
approach that allows us to accomplish this (Pfrieger and Slezak,
2012). On the other hand, we find that exocytotic glutamate re-
lease mediates glial volume regulation. Toxin-expressing Mu¨ller
cells were unable to counteract a volume increase induced by
hypotonic solution and this defect was compensated by coappli-
cation of glutamate. Similar osmotic swelling of Mu¨ller cells was
observed in knockout mice with impaired purinergic signaling
(Wurm et al., 2010). Together, these results support theis calculated from the Gaussian fit (solid lines). Right, distribution of latency
ck) and bigenic (red) mice. Positive values indicate that responses during high
no- and bigenic mice.
ell to a black and white bar moving at different velocities as indicated at the top
n response to the black and white bars. Bottom panel, individual tuning curves
lion cells. Values from Tam-injectedmono- and bigenicmicewere not different
tained by fitting a Suzuki-distribution to the velocity profiles of ganglion cells.
Figure 6. Light-Evoked Electrical Responses of the Retina with or without Glial Toxin Expression
(A and C) Representative single flash ERG recordings performed under scotopic (A) and photopic (C) conditions from an adult, Tam-injected monogenic (left) and
bigenic mouse (right) (iBot 3 Tg(Glast-CreERT2)). Flash intensities are indicated in (log (cd*s/m2)).
(B and D) Box plots of scotopic (B) and photopic (D) single flash ERG b-wave amplitudes in Tam-injected bigenic (red; n = 4) and monogenic mice (black; n = 4).
(E and G) Representative records of scotopic (E) and photopic (G) flicker frequency series at the stimulus intensity of 0.5 log cd*s/m2 from a monogenic (left) and
a bigenic mouse (right). Flicker frequencies are indicated in Hz.
(F and H) Box-plots of scotopic (F) and photopic (H) flicker amplitudes in monogenic (black; n = 4) and bigenic (red; n = 4) littermates. Boxes indicate the 25% and
75% quantile range and whiskers indicate the 5% and 95% quantiles. The solid lines connect median values. There were no differences between mono- and
bigenic mice.
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Figure 7. Integrative Functions of the Retina with or without Glial
Toxin Expression
(A) Mean fraction of time that mice spent on the exploration of a new object
compared to total time of exploration as revealed by the NOR test in adult,
Tam-injected male mice (circles, individual values; whiskers, standard devia-
tion; monogenic: n = 11; bigenic: n = 12; iBot 3 Tg(Glast-CreERT2)).
(B) Average latencies to find the visible platform in the water maze during
three consecutive days of training (whiskers, SEM;monogenic: n = 12; bigenic:
n = 11).
(C) Total distance of movement (left) and time spent in the central zone (right)
by adult, Tam-injected male mice as measured by the open field test (circles,
individual values; whiskers, standard deviation; monogenic: n = 17; bigenic:
n = 13).
(D) Representative actograms of an adult, Tam-injected monogenic and
a bigenic mouse that were kept under a 12/12 hr light (L)/dark (D) cycle for
19 days. Grey background, period of daily Tam injections. Onset of activity (E),
duration of activity (F) and fraction of nocturnal wheel turns compared to total
number of wheel turns (G) in bi- (red; n = 8) and monogenic (black; n = 7) mice
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signaling pathway that implies exocytotic release of glutamate
(Figure 4A; Wurm et al., 2008). We note that BoNT/B may also
affect constitutive exocytosis and vesicular transport in the en-
dosomal pathway (Proux-Gillardeaux et al., 2005; Hamilton
and Attwell, 2010). Our observation that glutamate fully restored
volume regulation in toxin-expressing glial cells suggests that
the glial release of ATP or adenosine, which is downstream
from glutamate (Figure 4A), is mediated by nonvesicular release.
Taken together, our results suggest that calcium-induced
vesicular releaseplays a role in glial physiology and that its contri-
bution depends on the astroglial cell type. This is in line with
previous studies on an alternative mouse model to study glio-
transmission in vivo. Block of exocytosis in GFAP-positive cells
by a dominant-negative SNARE domain of VAMP2 impaired glu-
tamatergic synaptic transmission in hippocampal slices (Pascual
et al., 2005) and perturbed sleep homeostasis, but left other brain
functions unaffected (Fellin et al., 2009; Halassa et al., 2009). On
the other hand, transgenic induction of calcium transients in
GFAP-positive cells did not affect excitatory synaptic activity
(Fiacco et al., 2007) and plasticity in hippocampal slices (Agulhon
et al., 2010). A full understanding of how gliotransmission con-
tributes to brain development, function, and pathology clearly
necessitates new experimental approaches to localize and per-
turb the different release mechanisms in astroglial cells in vivo.
EXPERIMENTAL PROCEDURES
Generation of Transgenic Mice
BoNT/B (Whelan et al., 1992) was amplified from the pBN13 vector (kind gift
from T. Galli) by PCR and cloned into the pCAGGS-lox-STOP-lox-IRES-
EGFP plasmid (Endoh et al., 2002; a kind gift from Dr. M. Endoh). Plasmids
containing the construct were amplified, purified (QIAGEN Plasmid Maxi Kit),
linearized, and injected into FVB/N mouse oocyte (Institut Clinique de la
Souris, ICS, Illkirch, France). Transgenic founders were backcrossed on the
C57Bl/6 background, and each line was screened for germline transmission.
For genotyping, genomic DNAwas isolated from tail biopsies (DirectPCR Lysis
Reagent Tail; Viagen Biotech) and subjected to standard PCR using specific
primers (Eurogentec) (EGFP: EGFP6F 50- GTAAACGGCCACAAGTTCAG;
EGFP6R 50-CGTCCTTGAAGAAGATGGTG; BoNT/B: BonTB8F 50-CGTGTTC
CACTCGAAGAGTT; BonTB8R 50-GGCAAAACTTCATTTGCATT; Cre: TK139
50-ATTTGCCTGCATTACCGGTC; TK141 50-ATCAACGTTTTGTTTTCGGA;
PCR control: ADV28 50-TTACGTCCATCGTGGACAGC; ADV30 50-TGGGCT
GGGTGTTAGCCTTA). Animals were bred at local facilities (Chronobiotron,
Strasbourg; animal house, Inst. Pharmacology, PAS, Krakow). All experi-
mental procedures involving animals and their care were performed in accor-
dance with French regulations on animal experimentation (Directive 86/609
CEE) and with the 2nd local Bioethics Commission (Inst. Pharmacology, PAS).
Tam Administration
Tam (Sigma) was administered to adult (1–3 months old) animals by intraper-
itoneal injection (2 mg from stock of 20 mg/ml in sunflower oil / ethanol 9:1).
Experiments were performed 2–4 weeks after the last injection. Postnatal
administration (5-day-old pups) was achieved by intraperitoneal injection of
lactating mothers (1 mg from 10 mg/ml stock) for 5 consecutive days at
24 hr intervals. Excess Tam was wiped off to exclude Tam ingestion by suck-
ling pups. Congestion of the vulva in female pups indicated that Tam had
passed to pups. Retarded growth of pups was counteracted by hydratedbefore and after Tam administration. There were no differences between
mono- and bigenic mice.
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diminish their fertility or interfere with subsequent pregnancies or deliveries.
Measurement of BoNT/B Activity
Measurements of VAMP2 and SYP levels in retinal lysates were performed by
surface plasmon resonance using antibodies directed against VAMP2 (Cl 69.1)
and SYP (Cl 7.2; Synaptic Systems) coupled to a CM3 sensor chip of a Biacore
3000 system. A nonimmune IgG (Jackson Immunoresearch) was used to
reduce nonspecific binding as described (Ferracci et al., 2005). Frozen retinae
were sonicated (3 3 2 s, 40W) in 300 ml of 10 mM HEPES/NaOH (pH 7.4),
0.32 M sucrose, 5 mM DTT as described (Marconi et al., 2008) and
10,000 3 g lysate supernatants were incubated at 37C during 30 min.
Samples were diluted in analysis buffer (50 mM Tris/HCl [pH 7.4], 0.4 M
NaCl) and the surface plasmon resonance signal was measured 20 s after
the end of each injection (20 ml/min).
Measurement of Calcium-Induced Glutamate Release
We used a fluorometric enzyme assay based on the Amplex Red Glutamic
Acid kit (Invitrogen) to visualize glutamate release from acutely isolated Mu¨ller
cells, which were identified by their unique morphology. Retinae were
incubated in papain (0.2 mg/ml; Roche Molecular Biochemicals) for 30 min
at 37C in the dark in Ca2+- and Mg2+-free extracellular solution (140 mM
NaCl, 3 mM KCl, 10 mM HEPES, 11 mM glucose [pH 7.4]), which was supple-
mented with glutamine (0.25 mM), glutamate (0.5 mM), methionine sulfoximine
(5 mM, Sigma) to block glutamine synthetase, and a photolabile calcium
chelator (O-nitrophenyl ethylene glycol tetraacetic acid acetoxymethyl;
NP-EGTA, 10mM; Invitrogen). After several washes with extracellular solution,
to whichMgCl2 (1 mM) andCaCl2 (2 mM)were added, retinae were triturated in
extracellular solution containing the components of the Amplex Red Glutamic
Acid kit (100 mM Amplex Red reagent, 0.5 U/ml horse radish peroxidase,
0.16 U/ml L-glutamate oxidase, 1.0 U/ml L-glutamate-pyruvate transaminase,
400 mML-alanine), NP-EGTA (10 mM), methionine sulfoximine (200 mM), and D,
L-threo-beta-benzyloxyaspartate (200 mM) to block glial glutamate uptake.
The cell suspension was mixed with 1% agarose and incubated for 15 min
in the recording chamber at 37C. In some experiments, bafilomycin A1
(200 nM, Biozol) was added. Resorufin fluorescence was imaged by confocal
laser microscopy (LSM510 Meta, 1003/1.3 Plan-Neofluar oil, Zeiss; 543 nm
helium-neon laser, 585 nm long pass filter, pinhole maximally open) above
Mu¨ller cell endfeet. Calcium transients were induced by four UV pulses
(351 nm/364 nm Enterprise UV Laser, 500 ms at maximal intensity) to release
calcium from NP-EGTA. Control experiments using fluo-4/AM (488 nm argon
laser; 505–550 nm band-pass filter) confirmed that each cell tested (15 out
of 15) showed UV-induced calcium transients. Peak amplitudes were calcu-
lated as difference between mean fluorescence intensity across four time
points acquired before and after the UV pulses.
Immunohistochemical Staining
Retinae were fixed with 4% paraformaldehyde by transcardiac perfusion of
mice or by incubation of isolated retinae in fixative for 45 min. Cryosections
or vibratome sections (embedded in 3% agarose) were blocked (2% bovine
serum albumin, Sigma; 5% normal goat or donkey serum plus 0.3% Triton
X-100 or 0.3% Triton X-100 plus 1% DMSO) and stained overnight with
biotinylated PNA (1:200, Sigma), with the nuclear stain TO-PRO-3 (1:1000,
Invitrogen) or with primary antibodies directed against CRALBP (mouse,
1:1000, Abcam), GFAP (mouse, 1:200, Sigma), Kv3.1b/KCNC1 (mouse,
1:200, Sigma), GFP (rabbit, 1:1000; Abcam), protein kinase C alpha (PKCa;
rabbit, 1:200, Genetex), vesicular glutamate transporter 1 (VGLUT1/SLC17A7;
guinea pig, 1:200, Synaptic Systems), and with secondary antibodies coupled
to Alexa Fluor 488 and Alexa Fluor 555 (Invitrogen) or Cy2-conjugated strepta-
vidin (Jackson Immunoresearch) for 1–3 hr at room temperature. Sections
were mounted in Mowiol (16.6% w/v, in PBS: glycerin 2:1; Calbiochem).
Images were taken with a laser scanning microscope (LSM 510 Meta) and
an Achroplan 633/0.9 water immersion objective (Zeiss).
Electron Microscopy
Mice were anesthetized by intraperitoneal injection of Ketamine (200 mg/kg)
and Xylazine (25 mg/kg) and fixed by transcardiac perfusion with glutaralde-hyde (2.5% in PBS at 7.4). Eyes were dissected and fixed for 1 hr in glutaral-
dehyde (2.5%) at room temperature (20C–24C). After three washes with
PBS, eyes were postfixed (1% OsO4 in PBS for 1 hr), dehydrated (ethanol at
25% for 10 min; 50% for 10 min, 70% for 10 min, 95% for 10 min and 100%
for 3 3 10 min; propylene oxide for 3 3 10 min) and embedded (Araldite M:
propylene oxide at 1:1 for 1 hr followed by Araldite M for 2 3 2 hr at room
temperature; polymerization at 60C for 3 days). Ultrathin sections were con-
trasted with uranyl acetate and inspected on a transmission electron micro-
scope (HITACHI 7500 with AMT camera, Hamamatsu).
Volume Regulation
Acutely isolated retinal slices (thickness, 1 mm; custom-made cutter) were
incubated in extracellular solution (see above) containing the vital dye Mito-
tracker Orange (10 mM, excitation: 543 nm, emission: 560 nm long-pass filter;
Invitrogen), which is taken up by Mu¨ller cells (Uckermann et al., 2004). Somata
of Mu¨ller cells were imaged at the plane of their maximal size using confocal
microscopy (LSM 510 Meta). In bigenic mice cells, which displayed EGFP
fluorescence (excitation: 488 nm; emission: 505 nm long-pass filter), were
selected. Hypotonic solution (60% of control osmolarity using distilled water)
and test substances were applied for 4min. Barium chloride (1mM)was added
to the extracellular solution 10 min before measurements. To study volume
changes in neuronal cell bodies, retinae were positioned in a perfusion
chamber with their vitreal surface up, labeled with FM1-43 (2 mM, Invitrogen
for 3 min; excitation 488 nm; emission 505 nm long-pass filter) to outline cells
and examined by confocal microscopy (LSM 510; Achroplan 633/0.9 water
immersion objective, Zeiss; pinhole 172 mm; optical section 1 mm). Image
stacks were obtained before and after 15 min perfusion with extracellular solu-
tion in the absence or presence of test substances. For analysis, the cross-
sectional areas of fluorescently labeled cell bodies in the ganglion cell or inner
nuclear layer of retinal slices were measured (Zeiss LSM Image Examiner
Version 3.2.0.70).
Electrophysiological Recordings
Electrophysiological recordings were performed on Purkinje cells in cerebellar
slices and on acutely isolated Mu¨ller cells by the whole-cell patch-clamp tech-
nique. Spike activity in the ganglion cell layer of retinae was recorded byMEAs
ex vivo. Light-evoked electrical responses of retinal layers were recorded by
ERGs in vivo. Details are described in Supplemental Information.
In Vivo Imaging
SLO images were obtained from anesthetized mice immediately after ERG
recordings as described previously using a Heidelberg Retina Angiograph
(HRA I) (Seeliger et al., 2005). Images were acquired under illumination with
an argon laser for fundus autofluorescence and EGFP detection (488 nm)
and red-free (RF) imaging of retinal structures (514 nm). OCT imaging was per-
formed immediately after SLOusing aSpectralis HRA+OCTdevice (Heidelberg
Engineering) and a broadband superluminescent diode at l = 880 nm as light
source (Huber et al., 2009). Adaptation for the optical qualities of the mouse
eye was achieved as described previously (Fischer et al., 2009).
Behavioral Tests
For behavioral tests the animals were kept in ventilated cages (Ehret) in
12/12 hr light/dark cycle with free access to food and water. The tests were
performed between hr 2 and 6 of the light phase and registered and analyzed
with the ANY-maze software (Stoelting). To assess visual perception of mice
several behavioral tests were performed with some modifications (Arque´
et al., 2008). For the NOR test, mice were placed at day 1 for 5min in the empty
open field apparatus (gray PVC box 403 403 34 cm, illumination 160 lux). At
day 2, mice were exposed for 10 min to an object A placed 5 cm from the wall.
After 3 min, the animals were exposed for 10 min to two objects: the previous
object A and a novel object B, positioned in two opposite corners, 5 cm from
the walls. Both objects presented similar textures, shapes, and sizes but
distinctive colors (white versus deep blue plastic caps, 4.5 cm diameter,
2.5 cmheight, randomly assigned as ‘‘old’’ or ‘‘novel’’). The novel object recog-
nition was assessed as the percentage of time the mice explored object B
compared to the time of exploration of both objects during the second trial
(NOR index = (time B/time A + B) * 100).Neuron 74, 504–516, May 10, 2012 ª2012 Elsevier Inc. 513
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eter), which was filled with water (temperature controlled at 22C ± 1C, illumi-
nation 50 lux at the center of the maze). The water was opaque by the addition
of white, nontoxic talcum powder (Pharma Cosmetic). Visual cues were posi-
tioned around the pool, 60 to 90 cm from its rim. The pool was divided into four
quadrants of equal area and a circular platform (15 cm height, 10 cm diameter)
was placed in the same quadrant for all trials. This platform, which stood out of
the water, was marked by tape and by a flag. At day 0 (24 hr before the exper-
iment) the mice swam freely for 2 min to find the platform and they were
allowed to spend 15 s on the platform (acclimatization). At days 1, 2, and 3
the animals were placed into the water facing the wall of the maze. They
were released from four different positions at the pool perimeter, each trial
lasted 90 s. The latencies to reach the platform were recorded.
For the open field test animals were placed in the center of the open-field
area (40 3 40 cm) that was equipped with a video camera placed above the
apparatus. Horizontal (locomotion) and vertical (rearings) activities were
measured for 10 min.
Actimetry
Transgenic mice were exposed to a 12/12 hr light/dark cycle (lights on at
7 a.m.) in cages equipped with running wheels (diameter 10 cm). Wheel-
running activity was recorded every 5 min (Vitalview acquisition system,
Minimitter). Onset and duration of running activity during the dark phase
were determined by visual inspection of actograms.
Statistical Analysis
Statistical analyses were performed using indicated tests (STATISTICA 9.1,
StatSoft Inc., Maison-Alfort, France). Whiskers in plots represent standard
deviation or standard error as indicated. Levels of significance are indicated
by asterisks and circles (* p < 0.05; ** p < 0.01; *** p < 0.001).
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and can be found with this article online at doi:10.1016/j.neuron.2012.03.027.
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